Search for a command to run...
Shree Pacetronix Ltd. showcases strong profitability with high ROE and decent revenue growth, but its high PE ratio indicates overvaluation. In comparison to its peers, it stands out in terms of efficiency metrics but faces competition from companies with better growth and valuation metrics.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Shree Pacetronix Ltd. | ₹167.30 | ₹60.22Cr | 80.08 | 34.76% | 0.33 |
POLYMED | ₹2,072.30 | ₹20,997.79Cr | 63.37 | 20.37% | 0.06 |
LAXMIDENTL | ₹340.30 | ₹1,870.36Cr | 100.52 | 21.79% | 0.99 |
Prevest Denpro Ltd. | ₹569.55 | ₹683.63Cr | 37.56 | 25.24% | - |
Hemant Surgical Industries Ltd. | ₹297.80 | ₹310.90Cr | 38.24 | - | - |
NURECA | ₹241.55 | ₹241.55Cr | -184.25 | -1.06% | 0.00 |
Raaj Medisafe India Ltd. | ₹84.59 | ₹111.77Cr | 18.23 | - | - |